Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.

Yao, S; Sucheston, L E; Zhao, H; Barlow, W E; Zirpoli, G; Liu, S; Moore, H C F; Thomas Budd, G; Hershman, D L; Davis, W; Ciupak, G L; Stewart, J A; Isaacs, C; Hobday, T J; Salim, M; Hortobagyi, G N; Gralow, J R; Livingston, R B; Albain, K S; Hayes, D F; Ambrosone, C B

Yao, S; Sucheston, L E; Zhao, H; Barlow, W E; Zirpoli, G; Liu, S; Moore, H C F; Thomas Budd, G; Hershman, D L; Davis, W; Ciupak, G L; Stewart, J A; Isaacs, C; Hobday, T J; Salim, M; Hortobagyi, G N; Gralow, J R; Livingston, R B; Albain, K S; Hayes, D F; Ambrosone, C B.

Affiliation

Yao S; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Sucheston LE; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Zhao H; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Barlow WE; SWOG Statistical Center, Seattle, WA, USA.
Zirpoli G; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Liu S; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Moore HC; Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH, USA.
Thomas Budd G; Department of Solid Tumor Oncology, Cleveland Clinic, Cleveland, OH, USA.
Hershman DL; Columbia University Medical Center, Columbia University, New York, NY, USA.
Davis W; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Ciupak GL; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.
Stewart JA; Department of medicine, Baystate Medical Center, Springfield, MA, USA.
Isaacs C; Lombardi Comprehensive Cancer Center, Washington, DC, USA.
Hobday TJ; Mayo Clinic, Rochester, MN, USA.
Salim M; Allan Blair Cancer Centre, Regina, SK, Canada.
Hortobagyi GN; Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA.
Gralow JR; Seattle Cancer Care Alliance, Seattle, WA, USA.
Livingston RB; College of Medicine, Arizona Cancer Center, Tucson, AZ, USA.
Albain KS; Loyola University Chicago Cardinal Bernardin Cancer Center, Maywood, IL, USA.
Hayes DF; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA.

Pharmacogenomics J ; 14(3): 241-7, 2014 Jun.

Article de En | MEDLINE | ID: mdl-23999597

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du sein / Protocoles de polychimiothérapie antinéoplasique / Protéines associées à la multirésistance aux médicaments / Aldehyde dehydrogenase Type d'étude: Etiology_studies / Risk_factors_studies Limites: Female / Humans Langue: En Journal: Pharmacogenomics J Sujet du journal: BIOLOGIA MOLECULAR / FARMACOLOGIA Année: 2014 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google